News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...

Recent Postings



ADVENTRIX (ANX) Vertex (VRTX) Sanofi (SNY) Vitae Pharmaceuticals (VTAE) ARGOS (ARGS) NEKTAR (NKTR)) SERES THERAPEUTICS (MCRB) Intermune (ITMN) CRISPR Therapeutics (CRSP) ARCA (ABIO) CompuGen (CGEN) Anadys (ANDS) INNOVIVA (INVA) SYNTA (SNTA) Ziofpharm (ZIOP) Prosensa (RNA) Dynavax (DVAX) Prolor Biotech (PBTH) ACADIA (ACAD) GUARDIAN HEALTH Intrexon (XON) Alder Biopharmaceuticals (ALDR) GlaxoSmithKline (GSK) AERIE PHARMACEUTICALS Dendreon (DNDN) Multiple Myeloma Intercept (ICPT) Theravance (THRX) Onyx (ONXX) Amgen (AMGN) Incyte (INCY) Ridaforolimus Tysabri Herceptin NOVOCURE (NVCR) HALOZYME (HALO) MODERNA Aimmune Therapeutics (AIMT) Theravance Bio Pharma (TBPH) Alnylam (ALNY) Anacor (ANAC) Endometrial Cancer Roche (RHHBY) KERYX (KERX) ABBVIE (ABBV) REGULUS (RGLS) Mirati Therapeutics (MRTX) Idenix (IDIX) KITE (KITE) Spike Therapeutics (ONCE) Genentech PTC Therapeutics (PTCT) Sangamo (SGMO) Exelixis (EXEL) Gilead (GILD) Pluristem (PSTI) BIOMARIN (BMRN) Ionis (IONS) Adaptimmune (ADAP) Abbott Laboratories (ABT) Human Longevity (HLI) Trastuzumab-DM1 Sanofi-Aventis (SAN) AstraZeneca (AZN) NANTKWEST (NK) ZALTRAP™ Agenus (AGEN) Human Genome Sciences (HGSI) OSI (OSIP) Bellicum (BLCM) CEMPRA (CEMP) Sequenom (SQNM) galapagos (GLPG) Rapamune Micromet (MITI) C4 Therapeutics Telaprevir Bristol-Myers Squibb (BMY) Valeant Pharmaceuticals International (VRX) ImmunoGen (IMGN) Galena (GALE) Sanofi (SNA) Cytokinetics (CYTK) Revlimid (lenolidamide) Roche (ROCHE) Seattle Genetics (SGEN) Benlysta (belimumab) Inovio (INO) Xoma (XOMA) JUNO (JUNO) Array Pharmaceuticals (ARRY) VANDA (VNDA) IDERA (IDRA) Biocryst (BCRX) Global Cell Therapeutics (GBT) Advaxis (ADXS) Illumina (ILMN) Elan (ELN) Ariad (ARIA) Editas (EDIT) Zerenex Auspex (ASPX) Biogen Idec (BIIB) Merck (MRK) TOKAI (TKAOI) ISIS (ISIS) Ocular Therapeutix (OCUL) RenenxBio (RGNX) Agenus (AGEN Sarepta (SRPT) SUNESIS PHARMACEUTICALS (SNSS) Jazz Pharmaceuticals (JAZZ) Regeneron (REGN) Velcade (bortezomib) AGOS (ARGS)